Omalizumab for severe food allergies: weight-based dosing study
Part of Immune system & allergy clinical trials.
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be allergic to at least two of these foods: peanut, cashew, walnut, egg, or milk, confirmed by a skin test and blood test.
- You must have had a serious allergic reaction to one of these foods in the past (other than the food used in the final challenge test).
- You must be willing to undergo an oral food challenge to confirm your allergy to one of the qualifying foods.
- Your weight must be 80 kg (about 176 lbs) or less.
- You cannot have poorly controlled asthma or a history of very severe anaphylaxis (like needing a breathing tube or ICU stay).
- You cannot be taking certain medications like steroids, beta-blockers, or tricyclic antidepressants currently.
- You cannot have had food immunotherapy (like allergy shots or oral drops) in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives a few doses of omalizumab (a medicine that blocks allergic reactions) and then does a food challenge to see if the patient can eat the food safely. It is for people who have already been prescribed this medicine for food allergy.
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
This study tests if omalizumab, an allergy medicine, can help people with COPD who are allergic to common indoor allergens and have had recent flare-ups. It aims to see if reducing allergic reactions can improve COPD control.
This trial studies an oral immunotherapy approach, where children take tiny, controlled amounts of certain allergy-causing foods to build tolerance. It may help reduce allergic reactions, but only if kids meet safety and monitoring requirements.
This study tests if omalizumab (Xolair), an injectable medicine that blocks allergy antibodies, can help people with food allergies tolerate small amounts of their trigger foods. It's for people with high total IgE levels who were not eligible for a related study.
This study tests a medication called omalizumab (a common allergy drug) to see if it can help people with severe allergies to plant foods like peach and melon, especially when standard treatments have failed. If you qualify, you may receive the drug and be monitored to see if your food allergies improve.
Hear when a new Food Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.